These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33569807)

  • 1. Treatment of periodontal intrabony defects using bovine porous bone mineral and guided tissue regeneration with/without platelet-rich fibrin: A randomized controlled clinical trial.
    Liu K; Huang Z; Chen Z; Han B; Ouyang X
    J Periodontol; 2021 Nov; 92(11):1546-1553. PubMed ID: 33569807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of platelet-rich plasma, bovine porous bone mineral, and guided tissue regeneration versus platelet-rich plasma and bovine porous bone mineral in the treatment of intrabony defects: a reentry study.
    Lekovic V; Camargo PM; Weinlaender M; Vasilic N; Kenney EB
    J Periodontol; 2002 Feb; 73(2):198-205. PubMed ID: 11895286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-rich plasma and bovine porous bone mineral combined with guided tissue regeneration in the treatment of intrabony defects in humans.
    Camargo PM; Lekovic V; Weinlaender M; Vasilic N; Madzarevic M; Kenney EB
    J Periodontal Res; 2002 Aug; 37(4):300-6. PubMed ID: 12200975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-rich fibrin and bovine porous bone mineral vs. platelet-rich fibrin in the treatment of intrabony periodontal defects.
    Lekovic V; Milinkovic I; Aleksic Z; Jankovic S; Stankovic P; Kenney EB; Camargo PM
    J Periodontal Res; 2012 Aug; 47(4):409-17. PubMed ID: 22126591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A surgical reentry study on the influence of platelet-rich plasma in enhancing the regenerative effects of bovine porous bone mineral and guided tissue regeneration in the treatment of intrabony defects in humans.
    Camargo PM; Lekovic V; Weinlaender M; Divnic-Resnik T; Pavlovic M; Kenney EB
    J Periodontol; 2009 Jun; 80(6):915-23. PubMed ID: 19485821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. INTRABONY DEFECT TREATMENT WITH PLATELET-RICH FIBRIN, GUIDED TISSUE REGENERATION AND OPEN-FLAP DEBRIDEMENT: A RANDOMIZED CONTROLLED TRIAL.
    Pham TAV
    J Evid Based Dent Pract; 2021 Sep; 21(3):101545. PubMed ID: 34479673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-Rich Fibrin Combined With a Porous Hydroxyapatite Graft for the Treatment of 3-Wall Intrabony Defects in Chronic Periodontitis: A Randomized Controlled Clinical Trial.
    Pradeep AR; Bajaj P; Rao NS; Agarwal E; Naik SB
    J Periodontol; 2017 Dec; 88(12):1288-1296. PubMed ID: 29314065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of platelet-rich plasma in the treatment of periodontal intrabony defects in humans.
    Ouyang XY; Qiao J
    Chin Med J (Engl); 2006 Sep; 119(18):1511-21. PubMed ID: 16996004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A reentry study on the use of bovine porous bone mineral, GTR, and platelet-rich plasma in the regenerative treatment of intrabony defects in humans.
    Camargo PM; Lekovic V; Weinlaender M; Vasilic N; Madzarevic M; Kenney EB
    Int J Periodontics Restorative Dent; 2005 Feb; 25(1):49-59. PubMed ID: 15736778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of growth factors in advanced platelet-rich fibrin and concentrated growth factors and their clinical efficacy as adjunctive to the GTR procedure in periodontal intrabony defects.
    Lei L; Yu Y; Han J; Shi D; Sun W; Zhang D; Chen L
    J Periodontol; 2020 Apr; 91(4):462-472. PubMed ID: 31471902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination use of bovine porous bone mineral, enamel matrix proteins, and a bioabsorbable membrane in intrabony periodontal defects in humans.
    Lekovic V; Camargo PM; Weinlaender M; Kenney EB; Vasilic N
    J Periodontol; 2001 May; 72(5):583-9. PubMed ID: 11394392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periodontal regeneration by leukocyte and platelet-rich fibrin with autogenous bone graft versus enamel matrix derivative with autogenous bone graft in the treatment of periodontal intrabony defects: A randomized non-inferiority trial.
    Paolantonio M; Di Tullio M; Giraudi M; Romano L; Secondi L; Paolantonio G; Graziani F; Pilloni A; De Ninis P; Femminella B
    J Periodontol; 2020 Dec; 91(12):1595-1608. PubMed ID: 32294244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a new-generation platelet-rich fibrin in the treatment of periodontal intrabony defects: a randomized clinical trial.
    Csifó-Nagy BK; Sólyom E; Bognár VL; Nevelits A; Dőri F
    BMC Oral Health; 2021 Nov; 21(1):580. PubMed ID: 34781955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison between enamel matrix proteins used alone or in combination with bovine porous bone mineral in the treatment of intrabony periodontal defects in humans.
    Lekovic V; Camargo PM; Weinlaender M; Nedic M; Aleksic Z; Kenney EB
    J Periodontol; 2000 Jul; 71(7):1110-6. PubMed ID: 10960017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injectable platelet-rich fibrin with demineralized freeze-dried bone allograft compared to demineralized freeze-dried bone allograft in intrabony defects of patients with stage-III periodontitis: a randomized controlled clinical trial.
    Alshoiby MM; Fawzy El-Sayed KM; Elbattawy W; Hosny MM
    Clin Oral Investig; 2023 Jul; 27(7):3457-3467. PubMed ID: 37002441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of platelet-rich fibrin for the treatment of periodontal intrabony defects: a systematic review and meta-analysis.
    Miron RJ; Moraschini V; Fujioka-Kobayashi M; Zhang Y; Kawase T; Cosgarea R; Jepsen S; Bishara M; Canullo L; Shirakata Y; Gruber R; Ferenc D; Calasans-Maia MD; Wang HL; Sculean A
    Clin Oral Investig; 2021 May; 25(5):2461-2478. PubMed ID: 33609186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet rich fibrin combined with decalcified freeze-dried bone allograft for the treatment of human intrabony periodontal defects: a randomized split mouth clinical trail.
    Agarwal A; Gupta ND; Jain A
    Acta Odontol Scand; 2016; 74(1):36-43. PubMed ID: 25972081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-Rich Fibrin in Regeneration of Intrabony Defects: A Randomized Controlled Trial.
    Patel GK; Gaekwad SS; Gujjari SK; S C VK
    J Periodontol; 2017 Nov; 88(11):1192-1199. PubMed ID: 28820322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of autologous platelet-rich fibrin and platelet-rich plasma in the treatment of 3-wall intrabony defects in chronic periodontitis: a randomized controlled clinical trial.
    Pradeep AR; Rao NS; Agarwal E; Bajaj P; Kumari M; Naik SB
    J Periodontol; 2012 Dec; 83(12):1499-507. PubMed ID: 22348695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of platelet-rich fibrin vs. enamel matrix derivative in the treatment of periodontal intrabony defects: a clinical and cone beam computed tomography study.
    Gupta SJ; Jhingran R; Gupta V; Bains VK; Madan R; Rizvi I
    J Int Acad Periodontol; 2014 Jul; 16(3):86-96. PubMed ID: 25654961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.